Return to search results.
Complete title: A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
|Research Study Number||GOG 0260|
|Principal Investigator||Heidi Gray, MD|
Fallopian Cancer; Gynecological Cancer; Ovarian Cancer; Solid Tumors; Primary Peritoneal Cancer (PPC)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.